Loading the section…

OMDA: financial statements from SEC — TradeAlmanac

OMDA

Omada Health, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	78M	68M	61M	55M	46M	41M
Cost of revenue	29M	23M	21M	23M	17M	16M
Gross profit	49M	45M	40M	32M	29M	25M
Research and development	13M	10M	10M	9M	9M	9M
Selling, general and administrative	14M	14M	12M	11M	11M	11M
Operating expenses	53M	48M	45M	40M	37M	35M
Operating income	−5M	−3M	−4M	−8M	−9M	−10M
Pre-tax income	−3M	−3M	−5M	−9M	−9M	−11M
Income tax	0	0	0	0	0	0
Net income	−3M	−3M	−5M	−9M	−9M	−11M
Earnings per share	−0.05	−0.06	−0.24	−1.15	−1.18	−1.40
Earnings per share, diluted	−0.05	−0.06	−0.24	−1.15	−1.18	−1.40
Weighted average shares	59M	58M	22M	8M	8M	8M
Weighted average shares, diluted	59M	58M	22M	8M	8M	8M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	212M	222M	199M	223M	59M	76M	84M	84M
Receivables	40M	35M	41M

Cash flow

Metric	31/03/2026	31/03/2025
Operating cash flow	−12M	−16M
Depreciation and amortisation	2M	1M
Share-based compensation	4M	3M
Capital expenditure	78,000	315,000
Investing cash flow	−2M	−1M
Financing cash flow	3M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator